(Press-News.org) Contact information: Julia S. Johansen
julia.johansen@post3.tele.dk
The JAMA Network Journals
Biomarkers in blood show potential as early detection method of pancreatic cancer
Researchers have identified diagnostic microRNA panels in whole blood that had the ability to distinguish, to some degree, patients with and without pancreatic cancer, according to a study in the January 22/29 issue of JAMA. The authors caution that the findings are preliminary, and that further research is necessary to understand whether these microRNAs have clinical implications as a screening test for early detection of pancreatic cancer.
MicroRNAs regulate gene expression and play important roles in the development of tumors and tumor metastasis. MicroRNA panels are a combination of several microRNAs.
Pancreatic cancer is the fourth most common cause of cancer death in the Western world and prognosis is poor, according to background information in the article. Early diagnosis of pancreatic cancer is difficult partly because it is difficult to get useful biopsies of tissue from patients suspected of having pancreatic cancer, so markers of the disease that could help with early diagnosis are needed to improve prognosis. Several specific microRNA profiles (patterns of microRNAs) have been linked to pancreatic cancer tissue. A diagnostic noninvasive blood test for pancreatic cancer would be very valuable, the authors write.
Nicolai A. Schultz, M.D., Ph.D., of Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark, and colleagues examined differences in microRNA in whole blood between patients with pancreatic cancer (n = 409) and healthy participants (n = 312) and patients with chronic pancreatitis (n = 25) to identify diagnostic panels of microRNAs for use in the diagnosis of pancreatic cancer. Serum cancer antigen 19-9 (CA19-9; an antigen that is elevated in approximately 80 percent of patients with pancreatic cancer) was also measured for comparison.
The researchers identified 2 novel panels with the potential for diagnosing pancreatic cancer.
The authors write that the test could result in referral of more individuals with symptoms to imaging. "The test could thereby diagnose more patients with pancreatic cancer, some of them at an early stage, and thus have a potential to increase the number of patients that can be operated on and possibly cured of pancreatic cancer."
They add that the harms of a high number of false-positives in screening for pancreatic cancer using an inexpensive, noninvasive blood sample from individuals with or without symptoms should be quantified in the future.
"Although we validated the panels, our findings are preliminary. … Further research is necessary to understand whether these have clinical implications for early detection of pancreatic cancer and how much this information adds to serum CA19-9."
(doi:10.1001/jama.2013.284664; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Will Detection of MicroRNA Biomarkers in Blood Improve the Diagnosis and Survival of Patients With Pancreatic Cancer?
In an accompanying editorial, Donald J. Buchsbaum, Ph.D., of the University of Alabama, Birmingham, and Carlo M. Croce, M.D., of Ohio State University, Columbus, write that additional research is needed regarding the use of microRNAs for the early detection of pancreatic cancer.
"Even though the study was relatively large, well-conducted, and addressed the important topic of development of noninvasive methods to detect pancreatic cancer, the authors appropriately acknowledge the exploratory nature of the investigation. … Given the dismal prognosis for patients with pancreatic cancer, it is important that new diagnostic approaches, such as the one used in this study, are sought. However, additional rigorous investigation will be necessary to support and extend these interesting findings."
(doi:10.1001/jama.2013.284665; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
### END
Biomarkers in blood show potential as early detection method of pancreatic cancer
2014-01-22
ELSE PRESS RELEASES FROM THIS DATE:
Many CV devices approved by process that often does not require new clinical data
2014-01-22
Many CV devices approved by process that often does not require new clinical data
Many cardiac implantable electronic device models currently in use were approved via a Food and Drug Administration review process in which the models were assumed safe and effective ...
Mediterranean diet associated with lower risk of peripheral artery disease
2014-01-22
Mediterranean diet associated with lower risk of peripheral artery disease
A multicenter study that previously reported a reduction in heart attack and stroke with a Mediterranean diet supplemented with extra-virgin olive oil or with nuts now also reports a ...
Deaths higher for heart attack patients at night and weekends
2014-01-22
Deaths higher for heart attack patients at night and weekends
Research: Off-hour presentation and outcomes in patients with acute myocardial infarction: systematic review and meta-analysis
Mortality is higher, and emergency treatment takes longer, for ...
Long term exposure to air pollution linked to coronary events
2014-01-22
Long term exposure to air pollution linked to coronary events
Association persists at levels of exposure below current European limits
Long term exposure to particulate matter in outdoor air is strongly linked to heart attacks and angina, and this association ...
Losing a family member in childhood associated with psychotic illness
2014-01-22
Losing a family member in childhood associated with psychotic illness
Highest risk seen in children who experience suicide in close family members
Experiencing a family death in childhood is associated with a small but significant increase in risk of psychosis, ...
Fast eye movements: A possible indicator of more impulsive decision-making
2014-01-22
Fast eye movements: A possible indicator of more impulsive decision-making
Using a simple study of eye movements, Johns Hopkins scientists report evidence that people who are less patient tend to move their eyes with greater speed. The findings, the researchers say, ...
Most high-risk cardiac devices in use today approved as modifications to previously-approved devices
2014-01-22
Most high-risk cardiac devices in use today approved as modifications to previously-approved devices
Device 'supplement' applications are generally not accompanied by new clinical testing, with implications for patient safety
Boston – The Food and Drug Administration ...
New sequencing tools give up close look at yeast evolution
2014-01-22
New sequencing tools give up close look at yeast evolution
Highlights in this week's Molecular Biology and Evolution
The baker's yeast Saccharomyces cerevisiae has been associated with human activities for thousands of ...
All FDA drug approvals not created equal
2014-01-22
All FDA drug approvals not created equal
Many patients and physicians assume that the safety and effectiveness of newly approved drugs is well understood by the federal Food and Drug Administration (FDA) —but a new study by researchers at Yale School of Medicine shows ...
Hedges and edges help pigeons learn their way around
2014-01-22
Hedges and edges help pigeons learn their way around
A study has found that homing pigeons' ability to remember routes depends on the complexity of the landscape below, with hedges and boundaries between urban and rural areas ...